Co-existence of Common Variable Immunodeficiency (CVID) with Idiopathic Thrombocytopenic Purpura (ITP)
Hegazi
Mohamed Osama
MO
Department of Medicine, Al Adan Hospital, Kuwait. drosama02@gmail.com
Kumar
Ramesh
R
Alajmi
Mubarak
M
Ibrahim
Eman
E
D000328:Adult; D000361:Agammaglobulinemia; D002180:Candidiasis, Oral / Q000139:chemically induced / Q000188:drug therapy; D017074:Common Variable Immunodeficiency / Q000150:complications* / Q000188:drug therapy; D005260:Female; D005500:Follow-Up Studies; D006562:Herpes Zoster / Q000139:chemically induced / Q000188:drug therapy; D006801:Humans; D006965:Hyperplasia; D016756:Immunoglobulins, Intravenous / Q000008:administration & dosage; D008533:Megakaryocytes / Q000473:pathology; D008775:Methylprednisolone / Q000008:administration & dosage; D011239:Prednisolone / Q000008:administration & dosage / Q000009:adverse effects; D016553:Purpura, Thrombocytopenic, Idiopathic / Q000150:complications* / Q000188:drug therapy; D013921:Thrombocytopenia / Q000188:drug therapy / Q000209:etiology
D016756:Immunoglobulins, Intravenous; D011239:Prednisolone; D008775:Methylprednisolone